CONTEXT: Evidence from animal studies suggests that the gradual rise in follicle-stimulating hormone (FSH) during reproductive senescence may contribute to the change in adiposity distribution characteristic of menopause. The potential independent role the interrelationships of FSH and estradiol (E2) may play in postmenopausal adiposity changes are not well studied. OBJECTIVE: Our objective was to evaluate the associations of FSH and dual x-ray absorptiometry (DXA)-derived adiposity measures, with consideration of estradiol and postmenopausal hormone therapy use. METHODS: In a sample of 667 postmenopausal women from the Women's Health Initiative Buffalo OsteoPerio Ancillary Study, we studied the associations of serum FSH and E2 levels with ...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Aim: To determine the impact on osteopenia/osteoporosis of serum follicle-stimulating hormone (FSH),...
Lipid metabolism disorder is a common pathological manifestation of menopausal women, and is also an...
Context: Whether menopause-related changes in sex steroids account for midlife weight gain in women ...
ObjectivesTo examine the impact of a weight loss intervention upon follicle stimulating hormone (FSH...
Introduction The association of serum follicle-stimulating hormone (FSH) level with body fat mass re...
PURPOSE: Increased follicle-stimulating hormone (FSH) has been associated with lower bone mineral de...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109940/1/oby20917.pd
Contains fulltext : 81450.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
OBJECTIVE: To assess the glycoform distribution patterns of follicle-stimulating hormone (FSH) and l...
Steroid hormones are associated with the risk of postmenopausal breast cancer and evidence suggests ...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Steroid hormones are associated with the risk of postmenopausal breast cancer and evidence suggests ...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Aim: To determine the impact on osteopenia/osteoporosis of serum follicle-stimulating hormone (FSH),...
Lipid metabolism disorder is a common pathological manifestation of menopausal women, and is also an...
Context: Whether menopause-related changes in sex steroids account for midlife weight gain in women ...
ObjectivesTo examine the impact of a weight loss intervention upon follicle stimulating hormone (FSH...
Introduction The association of serum follicle-stimulating hormone (FSH) level with body fat mass re...
PURPOSE: Increased follicle-stimulating hormone (FSH) has been associated with lower bone mineral de...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109940/1/oby20917.pd
Contains fulltext : 81450.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
OBJECTIVE: To assess the glycoform distribution patterns of follicle-stimulating hormone (FSH) and l...
Steroid hormones are associated with the risk of postmenopausal breast cancer and evidence suggests ...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Steroid hormones are associated with the risk of postmenopausal breast cancer and evidence suggests ...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Objective: Estradiol (E2) regulates adipose tissue resulting in increased fat mass (FM) with declini...
Aim: To determine the impact on osteopenia/osteoporosis of serum follicle-stimulating hormone (FSH),...
Lipid metabolism disorder is a common pathological manifestation of menopausal women, and is also an...